Correction of Previously Reported Information - (Details) (USD $)	2 Months Ended		3 Months Ended			9 Months Ended			12 Months Ended				33 Months Ended
	Mar. 31, 2014		Mar. 31, 2014		Mar. 31, 2013	Mar. 31, 2014		Mar. 31, 2013	Jun. 30, 2013		Jun. 30, 2012		Mar. 31, 2014
Derivative liabilities	$ 3,530,995	[1],[2]	$ 3,530,995	[1],[2]		$ 3,530,995	[1],[2]			[3]			$ 3,530,995	[1],[2]
Additional paid-in capital	(238,674)	[1],[2]	(238,674)	[1],[2]		(238,674)	[1],[2]			[3]			(238,674)	[1],[2]
Deficit accumulated during the development stage	(4,724,476)	[1],[2]	(4,724,476)	[1],[2]		(4,724,476)	[1],[2]		(1,370,844)	[3]			(4,724,476)	[1],[2]
Total liabilities and stockholders' deficit	2,997,129	[1],[2]	2,997,129	[1],[2]		2,997,129	[1],[2]		41,023	[3]			2,997,129	[1],[2]
Loss from operations			1,829,118	[2]	237,667	2,061,880	[2]	578,561					3,426,602	[2]
Realized and unrealized loss on derivatives			(2,380,540)	[2]		(2,380,540)	[2]						(2,380,540)	[2]
Total other income (expenses)			(2,785,501)	[2]	(900)	(2,793,842)	[2]	(1,908)					(2,799,964)	[2]
Loss from continuing operations			(4,614,619)	[2]	(238,567)	(4,855,722)	[2]	(580,469)					(6,226,566)	[2]
Loss from discontinued operations			(212,479)	[2]		(212,479)	[2]						(212,479)	[2]
Net loss	(4,724,476)		(4,827,098)	[2]	(238,567)	(5,068,201)	[2]	(580,469)	(886,877)	[3]	(483,967)	[3]	(6,439,045)	[2]
Scenario, Previously Reported [Member]
Derivative liabilities	986,905		986,905			986,905							986,905
Additional paid-in capital	587,139		587,139			587,139							587,139
Deficit accumulated during the development stage	(3,006,199)		(3,006,199)			(3,006,199)							(3,006,199)
Total liabilities and stockholders' deficit	2,997,129		2,997,129			2,997,129							2,997,129
Loss from operations			(1,829,118)			(2,061,880)							(3,426,602)
Realized and unrealized loss on derivatives			(662,263)			(662,263)							(662,263)
Total other income (expenses)			(1,067,224)			(1,075,565)							(1,081,687)
Loss from continuing operations			(2,896,342)			(3,137,445)							(4,508,289)
Loss from discontinued operations			(212,479)			(212,479)							(212,479)
Net loss			(3,108,821)			(3,349,924)							(4,720,768)
Scenario, Adjustment [Member]
Derivative liabilities	2,544,090		2,544,090			2,544,090							2,544,090
Additional paid-in capital	(825,813)		(825,813)			(825,813)							(825,813)
Deficit accumulated during the development stage	(1,718,277)		(1,718,277)			(1,718,277)							(1,718,277)
Total liabilities and stockholders' deficit
Loss from operations
Realized and unrealized loss on derivatives			(1,718,277)			(1,718,277)							(1,718,277)
Total other income (expenses)			(1,718,277)			(1,718,277)							(1,718,277)
Loss from continuing operations			(1,718,277)			(1,718,277)							(1,718,277)
Loss from discontinued operations
Net loss			(1,718,277)			(1,718,277)							(1,718,277)
Scenario, Actual [Member]
Derivative liabilities	3,530,995		3,530,995			3,530,995							3,530,995
Additional paid-in capital	(238,674)		(238,674)			(238,674)							(238,674)
Deficit accumulated during the development stage	(4,724,476)		(4,724,476)			(4,724,476)							(4,724,476)
Total liabilities and stockholders' deficit	2,997,129		2,997,129			2,997,129							2,997,129
Loss from operations			(1,829,118)			(2,061,880)							(3,426,602)
Realized and unrealized loss on derivatives			(2,380,540)			(2,380,540)							(2,380,540)
Total other income (expenses)			(2,785,501)			(2,793,842)							(2,799,964)
Loss from continuing operations			(4,614,619)			(4,855,722)							(6,226,566)
Loss from discontinued operations			(212,479)			(212,479)							(212,479)
Net loss			$ (4,827,089)			$ (5,068,201)							$ (6,493,045)

[1] California Gold Corp. and Subsidiaries

[2] Restated

[3] MV Patents, LLC